从恒瑞离职四年多后,周云曙履新港股创新药企先声药业(2096.HK)。据“江苏省肿瘤医院官方平台”2025年12月30日发布的消息,江苏省肿瘤医院(南京医科大学附属肿瘤医院)“江苏省恶性肿瘤先进诊疗重点实验室”与先声药业“神经与肿瘤药物研发全国重点实验室”正式签署战略合作协议。出席此次会议的嘉宾包括先声药业集团总裁周云曙。周云曙出席江苏省肿瘤医院活动周云曙曾是恒瑞医药(600276)元老级人物,还...
Source Link从恒瑞离职四年多后,周云曙履新港股创新药企先声药业(2096.HK)。据“江苏省肿瘤医院官方平台”2025年12月30日发布的消息,江苏省肿瘤医院(南京医科大学附属肿瘤医院)“江苏省恶性肿瘤先进诊疗重点实验室”与先声药业“神经与肿瘤药物研发全国重点实验室”正式签署战略合作协议。出席此次会议的嘉宾包括先声药业集团总裁周云曙。周云曙出席江苏省肿瘤医院活动周云曙曾是恒瑞医药(600276)元老级人物,还...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.